Insight Molecular Diagnostics (IMDX) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to -$12.9 million.
- Insight Molecular Diagnostics' Other Gross PP&E Adjustments fell 1501.87% to -$12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.9 million, marking a year-over-year decrease of 1501.87%. This contributed to the annual value of -$11.5 million for FY2024, which is 2363.03% down from last year.
- Latest data reveals that Insight Molecular Diagnostics reported Other Gross PP&E Adjustments of -$12.9 million as of Q3 2025, which was down 1501.87% from -$12.6 million recorded in Q2 2025.
- Insight Molecular Diagnostics' 5-year Other Gross PP&E Adjustments high stood at $4.7 million for Q2 2021, and its period low was -$15.7 million during Q3 2022.
- For the 5-year period, Insight Molecular Diagnostics' Other Gross PP&E Adjustments averaged around -$8.1 million, with its median value being -$11.1 million (2023).
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first skyrocketed by 44167.87% in 2021, then tumbled by 46248.28% in 2023.
- Insight Molecular Diagnostics' Other Gross PP&E Adjustments (Quarter) stood at -$4.5 million in 2021, then plummeted by 203.02% to -$13.7 million in 2022, then soared by 32.45% to -$9.3 million in 2023, then fell by 23.63% to -$11.5 million in 2024, then decreased by 12.64% to -$12.9 million in 2025.
- Its last three reported values are -$12.9 million in Q3 2025, -$12.6 million for Q2 2025, and -$12.7 million during Q1 2025.